Patients in the EU with rare disease thymidine kinase 2 deficiency (TK2d) could be just weeks away from having the first ...
EMA committee recommends marketing approval for UCB’s Kygevvi to treat thymidine kinase 2 deficiency
EMA committee recommends marketing approval for UCB’s Kygevvi to treat thymidine kinase 2 deficiency: Brussels, Belgium Monday, February 2, 2026, 15:00 Hrs [IST] UCB, a global b ...
Prime Women on MSN
Harnessing the powers of nature and science for improved longevity
Aging is inevitable, but getting old is a choice. And while we can’t stop the clock, we can make the most of the time remaining. Neurogan can help keep you on the right path.
NEW YORK CITY, NY / ACCESS Newswire / February 1, 2026 / Peripheral neuropathy has become one of the fastest-growing quality-of-life challenges in 2026, especially among people living with diabetes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results